Daratumumab enhances treatment efficacy in newly diagnosed multiple myeloma, showing improved MRD negativity and ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

J&J has a multi-year head start, but Gilead believes it can win market share by delivering a drug with better safety and at ...

Chicago, May 15, 2025 (GLOBE NEWSWIRE) -- The global multiple myeloma market is witnessing steady ... and biomarker-based diagnostics like serum M protein levels and del(17p) detection.

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials. The candidate in question, an oral p300 ...

MBD was detected using axial survey in My9 and My11, axial skeletal survey (2001–2010) and whole body computed tomography (2011 onwards) in HdB and combined skeletal survey and skeletal computed ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma. More therapies are being developed, to the point where somebody diagnosed now is likely to have ...

today announced new positive data from its pivotal Phase 2 iMMagine-1 study of anitocabtagene autoleucel (anito-cel), in patients with relapsed or refractory multiple myeloma (RRMM). These data ...